Leflunomide (Arava™) is a useful DMARD in Indian (Asian) patients: a clinic-based observational study of 1-year treatment

Author: Chopra Arvind   Saluja Manjit   Lagu-Joshi Vaijayanti   Sarmukadam Sanjiv  

Publisher: Springer Publishing Company

ISSN: 0770-3198

Source: Clinical Rheumatology, Vol.27, Iss.8, 2008-08, pp. : 1039-1044

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next